Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive 'Bio-Imaging' Using Quantitative Coronary Plaque Composition Assessment and the High-sensitive Troponin T for the Prediction of Cardiac Outcomes.

NCT02030704 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT02030704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02030704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive 'Bio-Imaging' Using Quantitative Coronary Plaque Composition Assessment and the High-sensitive Troponin T for the Prediction of Cardiac Outcomes.
Lead sponsor
University Hospital Heidelberg
Phase
Observational
Overall status
Completed
Start date
February 29, 2008
Completion date
September 30, 2018
Enrollment
300 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, noninvasive plaque characterization